Pnc Financial Services Group, Inc. Protagonist Therapeutics, Inc Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,441 shares of PTGX stock, worth $70,436. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,441
Previous 1,729
16.66%
Holding current value
$70,436
Previous $77,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PTGX
# of Institutions
252Shares Held
58MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$290 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$281 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$269 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$206 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$163 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.4B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...